SEE ALL INVESTMENTS Omnicare Omnicare is a leading platform for outpatient oncology care. Founded in 2002, Omnicare primarily distributes finished medicinal products to a nationwide network of compounding pharmacies for the patient-specific production of cancer drugs. Since 2012, the business has expanded its offering by developing additional services for highly specialised pharmacies and medical clinics in quality assurance, monitoring cleanroom hygiene, as well as training and development of specialist staff. These services were extended in 2019 through the creation of the Omnicare Quality Initiative, which aims to ensure the safe and high-quality care of oncology patients. Omnicare has also established the German Oncological Network of leading oncology practices in 2018, which aims to strengthen and further develop oncological practices in the interests of patients. Headquartered in Unterföhring near Munich, the business has additional sites in Cologne and Calw, supported by 193 employees who provide a service that enables outpatients to more quickly access specialist medicine and services close to where they live. INVESTMENT DATE Oct 2019 COUNTRY Germany BUSINESS DESCRIPTION Healthcare REVENUE AT ACQ. €703m EMPLOYEES AT ACQ. 193 INVESTMENT TYPE Primary MBO With Equistone’s support, we want to continue improving local and outpatient care for cancer patients in Germany. Oliver Tamimi, Chief Executive, Omnicare EQUISTONE TEAM In memoriam: Dirk Schekerka Senior Partner Munich Alexis Milkovic Partner Munich Julia Lucà Investment Director Munich Philipp Gauß Investment Manager Munich RELATED PRESS RELEASES Equistone to acquire a majority stake in Omnicare 14 Aug 2019 CONTACT US AMSTERDAM BIRMINGHAM LONDON MANCHESTER MUNICH PARIS ZURICH PRINT PAGE DISCLAIMER PRIVACY POLICY MODERN SLAVERY ACT INVESTOR LOGIN Equistone Partners Europe Limited is authorised and regulated by The Financial Conduct Authority. © EQUISTONE PARTNERS EUROPE